These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12948397)

  • 1. Differential modulation of glucocorticoid action by FK506 in A549 cells.
    Croxtall JD; Paul-Clark M; Van Hal PT
    Biochem J; 2003 Nov; 376(Pt 1):285-90. PubMed ID: 12948397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output.
    Whittle WL; Gibb W; Challis JR
    Placenta; 2000 May; 21(4):394-401. PubMed ID: 10833375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation.
    Brewer JA; Khor B; Vogt SK; Muglia LM; Fujiwara H; Haegele KE; Sleckman BP; Muglia LJ
    Nat Med; 2003 Oct; 9(10):1318-22. PubMed ID: 12949501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.
    Scammell JG; Denny WB; Valentine DL; Smith DF
    Gen Comp Endocrinol; 2001 Nov; 124(2):152-65. PubMed ID: 11703081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
    Medh RD; Lay RH; Schmidt TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):11-23. PubMed ID: 9685211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts.
    Migita K; Tanaka H; Okamoto K; Yoshikawa N; Ichinose Y; Urayama S; Yamasaki S; Ida H; Kawabe Y; Kawakami A; Eguchi K
    Lab Invest; 2000 Feb; 80(2):135-41. PubMed ID: 10701683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa.
    Labrande C; Velly L; Canolle B; Guillet B; Masmejean F; Nieoullon A; Pisano P
    Neuroscience; 2006; 137(1):231-9. PubMed ID: 16289353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus-superantigen decreases FKBP51 mRNA expression and cell-response to suppressive efficacy of a glucocorticoid in human peripheral blood mononuclear cells: possible implication of mitogen-activated protein kinase pathways.
    Fukushima H; Hirano T; Oka K
    Eur J Pharmacol; 2007 Sep; 570(1-3):222-8. PubMed ID: 17610867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of RU486 reveal distinct mechanisms for glucocorticoid repression of prostaglandin E release.
    Chivers JE; Cambridge LM; Catley MC; Mak JC; Donnelly LE; Barnes PJ; Newton R
    Eur J Biochem; 2004 Oct; 271(20):4042-52. PubMed ID: 15479233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.
    Croxtall JD; van Hal PT; Choudhury Q; Gilroy DW; Flower RJ
    Br J Pharmacol; 2002 Jan; 135(2):511-9. PubMed ID: 11815387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of glucocorticoids: role of lipocortins].
    Tranchant C; Braun S; Warter JM
    Rev Neurol (Paris); 1989; 145(12):813-8. PubMed ID: 2533385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.
    Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI
    Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids enhance the potency of Schwann cell mitogens.
    Neuberger TJ; Kalimi O; Regelson W; Kalimi M; De Vries GH
    J Neurosci Res; 1994 Jun; 38(3):300-13. PubMed ID: 7932865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells.
    Romano S; Mallardo M; Chiurazzi F; Bisogni R; D'Angelillo A; Liuzzi R; Compare G; Romano MF
    Haematologica; 2008 Jul; 93(7):1039-48. PubMed ID: 18492692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells.
    Pompeo A; Baldassare M; Luini A; Buccione R
    Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of glucocorticoid functions in an Anx-A1-/- cell line.
    Croxtall JD; Gilroy DW; Solito E; Choudhury Q; Ward BJ; Buckingham JC; Flower RJ
    Biochem J; 2003 May; 371(Pt 3):927-35. PubMed ID: 12553880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
    Fukunaga J; Yamaai T; Yamachika E; Ishiwari Y; Tsujigiwa H; Sawaki K; Lee YJ; Ueno T; Kirino S; Mizukawa N; Takagi S; Nagai N; Sugahara T
    Bone; 2004 Mar; 34(3):425-31. PubMed ID: 15003790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor.
    Chambers SK; Ivins CM; Kacinski BM; Hochberg RB
    Am J Obstet Gynecol; 2004 Apr; 190(4):974-85. PubMed ID: 15118624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS
    Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.